Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomas - Top-Institutions - MDSpire

Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomas

  • By

  • Julia A. Yescas

  • Christopher G. Bunick

  • Ayman Grada

  • Joan Guitart

  • Carlos A. Torres-Cabala

  • I. Caroline Le Poole

  • Xiaolong A. Zhou

  • May 13, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology Oncology
    • Dermatology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology Oncology
    • Dermatology

Original Source(s)

Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomas

  • by Julia A. Yescas, Christopher G. Bunick, Ayman Grada, Joan Guitart, Carlos A. Torres-Cabala, I. Caroline Le Poole, Xiaolong A. Zhou

  • May 13, 2026

Related Content

COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings

Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...

Early-Onset Lung Cancer May Be Connected to Pesticide Contaminants

Dietary patterns in young patients with lung cancer suggest that many have higher dietary quality scores than average U.S. reference values, according to results from a study presented at the American...

Unique Phase I NSCLC Trial Sites Decreasing in United States

The number of unique clinical trial sites in the United States with phase I studies for patients with non–small cell lung cancer (NSCLC) decreased by 44% from 2020 to 2024, showing a significant conso...